MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
Pfizer Depreciation & Amortization 2011-2026 | PFE
Annual Depreciation & Amortization Pfizer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.59 B | 7.01 B | 6.29 B | 5.06 B | 5.19 B | 4.68 B | 5.76 B | 6.38 B | 6.27 B | 5.76 B | 5.16 B | 5.54 B | 6.31 B | 7.39 B | 8.7 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.7 B | 4.68 B | 6.14 B |
Quarterly Depreciation & Amortization Pfizer
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.61 B | 1.66 B | 1.62 B | 1.62 B | 1.76 B | 1.73 B | 1.74 B | - | - | 1.49 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.1 B | 1.2 B | 1.77 B | - | 5.55 B | 3.89 B | 2.22 B | - | 6.57 B | 4.35 B | 2.1 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.57 B | 1.1 B | 2.47 B |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
Enlivex Therapeutics Ltd.
ENLV
|
546 K | $ 0.81 | -3.11 % | $ 37 M |  Israel |
 |
Exelixis
EXEL
|
29.1 M | $ 46.21 | -5.11 % | $ 12.5 B | USA |
 |
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | USA |
 |
Fortress Biotech
FBIO
|
403 K | $ 2.43 | -4.71 % | $ 67.8 M | USA |
 |
Heron Therapeutics
HRTX
|
2.31 M | $ 1.24 | -5.73 % | $ 207 M | USA |
 |
Ionis Pharmaceuticals
IONS
|
10 M | $ 75.53 | -1.72 % | $ 12.1 B | USA |
 |
Kymera Therapeutics
KYMR
|
8.31 M | $ 85.56 | -0.81 % | $ 7.23 B | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
35.2 M | $ 212.11 | -8.79 % | $ 3.88 B | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
920 K | $ 22.02 | 2.51 % | $ 3.65 B | USA |
 |
Mirum Pharmaceuticals
MIRM
|
24.2 M | $ 100.27 | -8.92 % | $ 5.03 B | USA |
 |
MannKind Corporation
MNKD
|
12.3 M | $ 3.59 | 0.7 % | $ 1.1 B | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
105 K | $ 3.15 | - | $ 655 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.65 | 8.96 % | $ 6.01 M | Israel |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M |  Canada |
 |
Genprex
GNPX
|
6.69 K | $ 0.88 | -1.48 % | $ 821 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
32 K | $ 0.65 | -4.03 % | $ 3.56 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
700 K | $ 21.33 | -11.75 % | $ 2.71 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
1 K | - | 10.36 % | $ 9.8 M | USA |